Results 361 to 370 of about 932,842 (376)
Some of the next articles are maybe not open access.
Antifungal Susceptibility Testing: The Times They Are A-Changing
Clinical Microbiology Newsletter, 2019Antifungal susceptibility testing (AFST) has never been as mainstream as antibacterial susceptibility testing. That may soon change. We are in an unprecedented era of antifungal development which could change the usefulness of and demand for AFST. Here we lay out an argument for increased AFST capacity, discuss new antifungals that are likely to appear
Shawn R. Lockhart, Elizabeth L. Berkow
openaire +3 more sources
Susceptibility testing and antifungal agents
Clinical Microbiology Newsletter, 1980The microbiology laboratory plays a key role in establishing the diagnosis of systemic fungal infections, by recovering fungi in culture and/or detecting fungal constituents or metabolic products in body fluids. The laboratory's role in proriding pertinent information to help manage patients with documented systemic fungal infections is, however, less ...
openaire +2 more sources
Antifungal Susceptibility Testing of Dermatophytes
2021In order to help guide treatment, antifungal susceptibility testing is often performed in clinical microbiology laboratories. The results of these in vitro assays are used by clinicians to change therapy should resistance be detected, continue with current regimens with susceptible results, and as an aide in determining possible reasons for treatment ...
openaire +2 more sources
Antifungal susceptibility testing
Antimicrobic Newsletter, 1986Abstract The current status of antifungal susceptibility tests is very much in flux. There is ample evidence that current testing of fungi is at this point poorly standardized, and therefore the results from such tests are difficult to apply to patient management.
openaire +2 more sources
Antifungal Susceptibility Testing: A Primer for Clinicians
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2012Antifungal susceptibility testing is not as commonly performed as antibacterial susceptibility testing. The methodology for detecting antifungal resistance is newer and requires different testing supplies that may not be readily available in a clinical laboratory setting. Breakpoints for molds are lacking.
Elizabeth A. Coyle +2 more
openaire +3 more sources
Antifungal Susceptibility Testing and Therapy
2009The development of new therapies to treat fatal diseases is creating an increasing number of patients who have predisposing factors for infections by opportunistic yeasts. The rise in the prevalence of fungal infections has been the drive to develop and license several new antifungal agents such as new formulations of polyenes, new triazole agents and ...
Juan L. Rodriguez-Tudela +1 more
openaire +2 more sources
Trends in fungaemia and antifungal susceptibility in the Netherlands.
The Netherlands journal of medicine, 2006Item does not contain ...
Verduyn Lunel, F.M. +10 more
openaire +3 more sources
Etest for antifungal susceptibility testing of yeasts
Diagnostic Microbiology and Infectious Disease, 1994Comparison [+/- 1 dilution between minimum inhibitory concentrations (MICs)] of fluconazole and flucytosine Etest MICs of 10 candidate quality control yeast isolates and 78 clinical isolates demonstrated good agreement (> or = 90%) with the reference method (National Committee for Clinical Laboratory Standards document M27-P).
openaire +2 more sources
Standardization of antifungal susceptibility testing
Medical Mycology, 1992Michael G. Rinaldi +3 more
openaire +3 more sources
Antifungal susceptibility testing
2004During the past few decades, advances in medical technology and the development of new diagnostic and treatment approaches have increased the life expectancy of critically ill patients. The global human immunodeficiency virus (HIV) epidemic has resultedin an increase in severely ill immunocompromised hospitalized patients, accompanied by more reports ...
openaire +1 more source